India's Leap into Next-Gen Biotherapeutics: Miltenyi Biotec and BIRAC's Strategic Collaboration
Miltenyi Biotec India Private Limited and BIRAC have signed a strategic LOI to boost India's Cell and Gene Therapy capabilities. The collaboration focuses on building local scientific talent, enhancing clinical research, and establishing Point-of-Care manufacturing centers. This aligns with the Make in India mission, empowering innovation and improving therapeutics access.
- Country:
- India
Miltenyi Biotec India and the Biotechnology Industry Research Assistance Council (BIRAC) have joined forces in a pivotal alliance to propel India's capabilities in Cell and Gene Therapy (CGT). The strategic agreement was signed during the BIO International Convention 2025 in Boston.
This collaboration includes capacity-building initiatives and clinical research to address unmet medical needs through local manufacturing of CGT. It aims to establish Point-of-Care (PoC) CAR-T centers across India, enhancing the country's leadership in biotherapeutics.
The partnership supports the Make in India mission, emphasizing national innovation and infrastructure enhancement. By upskilling local talent and facilitating targeted research, India is positioning itself as a global hub in the biotech sector.
(With inputs from agencies.)
Google News